Cystaran

Active Ingredient(s): Cysteamine
FDA Approved: * October 2, 2012
Pharm Company: * SIGMA TAU
Category: Urinary System

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cystaran Overview

Cysteamine is a medication intended for a number of indications, and approved by the FDA to treat cystinosis. It is a stable aminothiol, i.e., an organic compound containing both an amine and a thiol functional groups. Cysteamine is a white, water-soluble solid. It is often used as salts of the ammonium derivative [HSCH2CH2NH3]+[1] including the hydrochloride, phosphocysteamine, and bitartrate.[2] Cysteamine molecule is biosynthesized in mammals, including hu...

Read more Cystaran Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cysteamine

Recent Cystaran Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Cystaran: (1 result)

Sorted by National Drug Code

• 54482-020 Cystaran 6.5 mg/ml Ophthalmic Solution by Sigma-tau Pharmaceuticals, Inc.

Other drugs which contain Cysteamine or a similar ingredient: (3 results)

• CYSTAGON Cysteamine1 discussion
• CYSTEAMINE
• PROCYSBI Cysteamine Bitartrate